Sponsor Pipeline

EIP Pharma Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07033481 Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Active, Not Recruiting
NCT06987643 A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After… Moderate to Severe Acute Ischaemic Stroke Active, Not Recruiting
Disease Areas
Stroke (1)
Get alerts when EIP Pharma Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free